GlyTech, Inc. Gives Lecture at the 2018 Joint Study Meeting of the Drug Discovery Consortium and Pharmaceutical Technology Consortium, Ritsumeikan University.

GlyTech, Inc. CEO Hiroaki Asai gave a lecture today at the 2018 Joint Study Meeting of the Drug Discovery Consortium and Pharmaceutical Technology Consortium led by Ritsumeikan University on the theme of Life Science Innovation in Kyoto. Mr. Asai spoke on how biopharmaceuticals can be created via glycoengineering using a chemical approach.

• Drug Discovery Consortium and Pharmaceutical Technology Consortium Joint Study Meeting 2018: Life Science Innovation in Kyoto (In Japanese)

Last updated: August 24th, 2018

Back to index of news